Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCHÖLKENS, B. A")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 36

  • Page / 2
Export

Selection :

  • and

A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramiprilLINZ, W; SCHÖLKENS, B. A.British journal of pharmacology. 1992, Vol 105, Num 4, pp 771-772, issn 0007-1188Article

Cardioprotective effects of ACE inhibitors : experimental proof and clinical perspectivesSCHÖLKENS, B. A; LINZ, W.Clinical physiology and biochemistry. 1990, Vol 8, pp 33-43, issn 0252-1164, 11 p., Suppl. 1Conference Paper

Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in ratsLINZ, W; SCHÖLKENS, B. A; GANTEN, D et al.Clinical and experimental hypertension. Part A, Theory and practice. 1989, Vol 11, Num 7, pp 1325-1350, issn 0730-0077Article

Kinin receptor antagonists : unique probes in basic and clinical researchWIRTH, K. J; HEITSCH, H; SCHÖLKENS, B. A et al.Canadian journal of physiology and pharmacology. 1995, Vol 73, Num 7, pp 797-804, issn 0008-4212Conference Paper

Biological activities of 6-keto-prostaglandin E1LEWIS, R; SCHÖLKENS, B. A; BECK, G et al.Prostaglandins leukotrienes and medicine. 1984, Vol 16, Num 3, pp 303-324, issn 0262-1746Article

The bradykinin B2 receptor antagonist WIN 64338 inhibits the effect of des-Arg9-bradykinin in endothelial cellsWIRTH, K. J; SCHÖLKENS, B. A; WIEMER, G et al.European journal of pharmacology. Molecular pharmacology section. 1994, Vol 288, Num 1, pp R1-R2, issn 0922-4106Article

Role of angiotensin II receptor antagonism and converting enzyme inhibition in the progression and regression of cardiac hypertrophy in ratsLINZ, W; HENNING, R; SCHÖLKENS, B. A et al.Journal of hypertension. 1991, Vol 9, pp S400-S401, issn 0263-6352, SUP6Conference Paper

Effects of colforsin, trequinsin and isoprenaline on norepinephrine-induced contractions and cyclic nucleotide levels of isolated vascular tissueLINZ, W; WIEMER, G; SCHÖLKENS, B. A et al.Arzneimittel-Forschung. 1988, Vol 38, Num 2, pp 240-243, issn 0004-4172Article

Does bradykinin play a role in the cardiac antiischemic effect of the ACE-inhibitors ?MARTORANA, P. A; LINZ, W; SCHOLKENS, B. A et al.Basic research in cardiology. 1991, Vol 86, Num 4, pp 293-296, issn 0300-8428Article

Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cellsWIEMER, G; POPP, R; SCHÖLKENS, B. A et al.Brain research. 1994, Vol 638, Num 1-2, pp 261-266, issn 0006-8993Article

Persistent tissue converting enzyme inhibition following chronic treatment with Hoe498 and MK421 in spontaneously hypertensive ratsUNGER, T; GANTEN, D; LANG, R. E et al.Journal of cardiovascular pharmacology. 1985, Vol 7, Num 1, pp 36-41, issn 0160-2446Article

Regulation of aortic atrial natriuretic factor and angiotensinogen in experimental hypertensionOGAWA, T; LINZ, W; SCHÖLKENS, B. A et al.Journal of cardiovascular pharmacology. 1998, Vol 32, Num 6, pp 1001-1008, issn 0160-2446Article

Novel series of o-substituted 8-quinolines and 4-benzothiazoles as potent antagonists of the bradykinin B2 receptorsHEITSCH, H; WAGNER, A; SCHÖLKENS, B. A et al.Bioorganic & medicinal chemistry letters (Print). 1999, Vol 9, Num 3, pp 327-332, issn 0960-894XArticle

Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction = Clinical interest of low dose of converting enzyme inhibitor : the HYCAR studyLINZ, W; GOHLKE, P; UNGER, T et al.Archives des maladies du coeur et des vaisseaux. 1995, Vol 88, pp 31-34, issn 0003-9683, NS2Conference Paper

Cardiovascular effects of the converting enzyme inhibitor ramipril (HOE 498) in anesthetized dogs with acute ischemic left ventricular failureSCHOLKENS, B. A; MARTORANA, P. A; GOBEL, H et al.Clinical and experimental hypertension. Part A, Theory and practice. 1986, Vol 8, Num i6, pp 1033-1048, issn 0730-0077Article

Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontanously hypertensive ratsGOHLKE, P; LINZ, W; SCHÖLKENS, B. A et al.Hypertension (Dallas, Tex. 1979). 1996, Vol 28, Num 3, pp 397-402, issn 0194-911XConference Paper

Technetium-99m-labeled HOE 140 : a potential bradykinin B2 receptor imaging agentSTAHL, W; BREIPOHL, G; KUHLMANN, L et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 15, pp 2799-2801, issn 0022-2623Article

Angiotensin-converting enzyme inhibition improves cardiac function : role of bradykininGOHLKE, P; LINZ, W; SCHÖLKENS, B. A et al.Hypertension (Dallas, Tex. 1979). 1994, Vol 23, Num 4, pp 411-418, issn 0194-911XArticle

HMR 1098 : An inhibitor of cardiac ATP-sensitive potassium channelsGÖGELEIN, H; ENGLERT, H. C; KOTZAN, A et al.Cardiovascular drug reviews (Print). 2000, Vol 18, Num 2, pp 157-174, issn 0897-5957Article

Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone ratsLINZ, W; BECKER, R. H. A; SCHÖLKENS, B. A et al.Kidney international. 1998, Vol 54, Num 6, pp 2037-2044, issn 0085-2538Conference Paper

Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusionSCHOLZ, W; ALBUS, U; COUNILLON, L et al.Cardiovascular research. 1995, Vol 29, Num 2, pp 260-268, issn 0008-6363Article

Bradykinin prevents left ventricular hypertrophy in ratsLINZ, W; WIEMER, G; SCHÖLKENS, B. A et al.Journal of hypertension. Supplement. 1993, Vol 11, Num 5, pp S96-S97, issn 0952-1178Conference Paper

Airway pharmacology of the potassium channel opener, HOE 234, in guinea pigs : in vitro and in vivo studiesENGLERT, H. C; WIRTH, K; GEHRING, D et al.European journal of pharmacology. 1992, Vol 210, Num 1, pp 69-75, issn 0014-2999Article

Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642)LINZ, W; ALBUS, U; CRAUSE, P et al.Clinical and experimental hypertension (1993). 1998, Vol 20, Num 7, pp 733-749, issn 1064-1963Article

Early induction of angiotensin I-converting enzyme in rat carotid artery after balloon injuryFERNANDEZ-ALFONSO, M. S; MARTORANA, P. A; LICKA, I et al.Hypertension (Dallas, Tex. 1979). 1997, Vol 30, Num 2, pp 272-277, issn 0194-911X, 1Article

  • Page / 2